BIOTIME INC Contracts & Agreements
191 Contracts & Agreements
- Business Finance (89 contracts)
- Business Operations (11)
- Human Resources (37)
- Intellectual Property (19)
- Mergers & Acquisitions (2)
- Real Estate (7)
- Uncategorized (26)
- Sales Agreement, dated March 22, 2024, by and between Lineage Cell Therapeutics, Inc. and B. Riley Securities, Inc (Filed With SEC on March 22, 2024)
- Separation, Release and Consulting Agreement dated November 30, 2023 between Registrant and Gary S. Hogge (Filed With SEC on March 7, 2024)
- Amendment to Stock Option Agreements dated December 4, 2023 between Registrant and Gary S. Hogge (Filed With SEC on March 7, 2024)
- Form of Stock Purchase Agreement (Filed With SEC on February 6, 2024)
- Employment Agreement dated November 14, 2022 between Registrant and Jill A. Howe (Filed With SEC on March 9, 2023)
- Stipulation and Agreement of Compromise and Settlement dated October 26, 2022 (Filed With SEC on March 9, 2023)
- Amended and Restated Employment Agreement between Lineage Cell Therapeutics, Inc. and Brian M. Culley (Filed With SEC on November 10, 2022)
- Amended and Restated Employment Agreement between Lineage Cell Therapeutics, Inc. and George A. Samuel III (Filed With SEC on November 10, 2022)
- Amended and Restated Employment Agreement between Lineage Cell Therapeutics, Inc. and Gary S. Hogge (Filed With SEC on November 10, 2022)
- Executive Performance Incentive Bonus Plan (Filed With SEC on November 10, 2022)
- Form of Indemnification Agreement for directors and executive officers of the registrant (Filed With SEC on August 11, 2022)
- Separation Agreement dated July 5, 2022, between Lineage Cell Therapeutics, Inc. and Kevin L. Cook (Filed With SEC on July 7, 2022)
- Debt and Note Purchase Agreement, dated June 16, 2017, and Amendment to Debt and Note Purchase Agreement, dated as of June 29, 2017, between registrant and HBL-Hadasit... (Filed With SEC on June 17, 2022)
- Share Purchase and Transfer Agreement, dated June 16, 2017, by and among registrant, HBL-Hadasit Bio-Holdings Ltd. and Cell Cure Neurosciences Ltd (Filed With SEC on June 17, 2022)
- Second Amendment to Hadasit License dated December 1, 2019 (Filed With SEC on March 10, 2022)
- Side Letter Agreement dated December 17, 2021 between Hadasit Medical Research Services and Development Ltd., Cell Cure Neurosciences Ltd., Genentech, Inc. and F. Hoffmann-La... (Filed With SEC on March 10, 2022)
- Second Side Letter Agreement dated December 17, 2021 between Hadasit Medical Research Services and Development Ltd. and Cell Cure Neurosciences Ltd (Filed With SEC on March 10, 2022)
- First Amendment to Separation and Consulting Agreement dated July 20, 2021, between Registrant and Brandi L. Roberts (Filed With SEC on November 10, 2021)
- Employment Agreement dated August 5, 2021, between Registrant and George A. Samuel III (Filed With SEC on November 10, 2021)
- Lineage Cell Therapeutics, Inc. 2021 Equity Incentive Plan (Filed With SEC on September 15, 2021)
- First Amendment to License Agreement dated April 16, 2021 between Cancer Research Technology Limited and Registrant (Filed With SEC on August 12, 2021)
- First Amendment to Separation and Consulting Agreement dated May 21, 2021 between Registrant and Chase C. Leavitt (Filed With SEC on August 12, 2021)
- Employment Agreement dated June 8, 2021, between Registrant and Kevin Leon Cook (Filed With SEC on August 12, 2021)
- Separation and Consulting Agreement dated March 29, 2021 between Registrant and Chase C. Leavitt (Filed With SEC on May 13, 2021)
- Description of Capital Stock of the Registrant (Filed With SEC on March 11, 2021)
- Separation and Consulting Agreement dated January 20, 2021 between Registrant and Brandi Roberts (Filed With SEC on March 11, 2021)
- Lease Termination Agreement dated September 11, 2020 (Filed With SEC on September 14, 2020)
- Second Amendment to Clinical Trial and Option Agreement dated May 6, 2020 between Cancer Research UK, Cancer Research Technology Limited (CRT), Asterias Biotherapeutics, Inc. and... (Filed With SEC on August 6, 2020)
- Agreement dated May 6, 2020 between CRT and Registrant (Filed With SEC on August 6, 2020)
- Description of Capital Stock of the Registrant (Filed With SEC on March 12, 2020)
- 2012 Plan Form of Restricted Stock Unit (Filed With SEC on March 12, 2020)
- Employment Agreement effective May 20, 2019, between Registrant and Chase Leavitt (Filed With SEC on March 12, 2020)
- Amendment to 2012 Equity Incentive Plan (Filed With SEC on November 12, 2019)
- Form of Stock Option Agreement under 2012 Equity Incentive Plan (Filed With SEC on November 12, 2019)
- Employment Agreement, dated March 18, 2019, between BioTime, Inc. and Edward D. Wirth, III (Filed With SEC on May 9, 2019)
- Inducement Option Grant Agreement for Brian Culley (Filed With SEC on March 14, 2019)
- Employment Agreement, effective January 7, 2019, between BioTime, Inc. and Brandi Roberts (Filed With SEC on March 14, 2019)
- Agreement and Plan of Merger dated November 7, 2018, among BioTime, Inc., Patrick Merger Sub, Inc. and Asterias Biotherapeutics, Inc (Filed With SEC on November 8, 2018)
- Employment Agreement, dated September 17, 2018, between BioTime, Inc. and Brian M. Culley (Filed With SEC on September 18, 2018)
- Transition Agreement, dated September 17, 2018, between BioTime, Inc. and Aditya P. Mohanty (Filed With SEC on September 18, 2018)
- Transition Agreement, dated September 17, 2018, between BioTime, Inc. and Michael D. West (Filed With SEC on September 18, 2018)
- Stock Purchase Agreement, dated August 30, 2018, between BioTime, Inc., AgeX Therapeutics, Inc. and Juvenescence Limited (Filed With SEC on August 31, 2018)
- Convertible Promissory Note, dated August 30, 2018 (Filed With SEC on August 31, 2018)
- Shareholder Agreement, dated August 30, 2018 between BioTime, Inc. and Juvenescence Limited (Filed With SEC on August 31, 2018)
- Letter Agreement, dated August 1, 2018, by and between BioTime, Inc. and Juvenescence Limited (Filed With SEC on August 2, 2018)
- Amendment, dated January 8, 2018, to Second Amended and Restated License Agreement, dated June 15, 2017, between Cell Cure Neurosciences, Ltd. and Hadasit Medical Research... (Filed With SEC on March 15, 2018)
- Asset Contribution and Separation Agreement, dated August 17, 2017, between BioTime, Inc. and AgeX Therapeutics, Inc (Filed With SEC on November 9, 2017)
- License Agreement, dated August 17, 2017, between BioTime, Inc. and AgeX Therapeutics, Inc (Filed With SEC on November 9, 2017)
- Option to Purchase Shares of AgeX Therapeutics, Inc., dated August 4, 2017, granted by BioTime, Inc. to Alfred D. Kingsley (Filed With SEC on November 9, 2017)
- AgeX Therapeutics, Inc. 2017 Equity Incentive Plan (Filed With SEC on October 16, 2017)
- Form of AgeX Therapeutics, Inc. Stock Option Agreement (Filed With SEC on October 16, 2017)
- Underwriting Agreement, dated October 13, 2017, by and between BioTime, Inc. and Raymond James & Associates, Inc., as representative of the underwriters named therein (Filed With SEC on October 13, 2017)
- Second Amended and Restated License Agreement, dated June 15, 2017, between Cell Cure Neurosciences, Ltd. and Hadasit Medical Research Services and Development Ltd. (Portions of... (Filed With SEC on August 9, 2017)
- Debt and Note Purchase Agreement, dated June 16, 2017, as amended June 29, 2017, between BioTime, Inc. and HBL-Hadasit Bio-Holdings Ltd. (Portions of this exhibit have been... (Filed With SEC on August 9, 2017)
- Share Purchase and Transfer Agreement, dated June 16, 2017, by and among BioTime, Inc. and HBL-Hadasit Bio-Holdings Ltd. and Cell Cure Neurosciences Ltd. (Portions of this exhibit... (Filed With SEC on August 9, 2017)
- Cell Cure Neurosciences Ltd. Share Option Plan (Filed With SEC on March 16, 2017)
- Form of Cell Cure Neurosciences Ltd. Share Option Plan Option Agreement (Filed With SEC on March 16, 2017)
- Underwriting Agreement, dated February 10, 2017, between BioTime, Inc. and Raymond James & Associates, Inc., as representative of the underwriters named therein (Filed With SEC on February 13, 2017)
- Form of Securities Purchase Agreement (Filed With SEC on August 29, 2016)
- Alternate Form of Securities Purchase Agreement (Filed With SEC on August 29, 2016)
- Form of Warrant (Filed With SEC on August 29, 2016)
- Second Amendment to License Agreement, dated January 25, 2016, between OncoCyte Corporation and The Wistar Institute of Anatomy and Biology (Filed With SEC on August 9, 2016)
- Underwriting Agreement, dated June 16, 2016, between BioTime, Inc. and Oppenheimer & Co. Inc (Filed With SEC on June 17, 2016)
- Separation Agreement, as of March 10, 2016, between Pedro Lichtinger and Asterias Biotherapeutics, Inc (Filed With SEC on May 10, 2016)
- Amendment to the Notice of Award from the California Institute of Regenerative Medicine dated March 2, 2016 (Portions of this exhibit have been omitted pursuant to a request for... (Filed With SEC on May 10, 2016)
- Warrant Agreement between Asterias Biotherapeutics, Inc. and American Stock Transfer & Trust Company (Filed With SEC on May 10, 2016)
- License Agreement, dated January 22, 2016, between OncoCyte Corporation and The Wistar Institute of Anatomy and Biology (Portions of this exhibit have been omitted pursuant to a... (Filed With SEC on March 15, 2016)
- First Amendment to License Agreement, dated January 25, 2016, between OncoCyte Corporation and The Wistar Institute of Anatomy and Biology (Filed With SEC on March 15, 2016)
- Cross License Agreement between Asterias Biotherapeutics, Inc., BioTime, Inc. and ES Cell International Pte Ltd (Filed With SEC on February 18, 2016)
- Share Transfer Agreement by and among Asterias Biotherapeutics, Inc., BioTime, Inc., and ES Cell International Pte Ltd (Filed With SEC on February 18, 2016)
- Lease, dated December 10, 2015, between BioTime, Inc. and BSREP Marina Village Owner LLC (Filed With SEC on December 15, 2015)
- Amendment of Employment Agreement, dated November 24, 2015, between BioTime, Inc. and Michael D. West (Filed With SEC on December 1, 2015)
- Amendment of Employment Agreement, dated November 24, 2015, between BioTime, Inc. and Aditya Mohanty (Filed With SEC on December 1, 2015)
- Employment Termination and Release Agreement, dated November 18, 2015, between BioTime, Inc. and Robert W. Peabody (Filed With SEC on November 24, 2015)
- Employment Agreement, dated November 18, 2015, between LifeMap Solutions, Inc. and Robert W. Peabody (Filed With SEC on November 24, 2015)
- Consulting Agreement, dated November 18, 2015, between BioTime, Inc. and Robert W. Peabody (Filed With SEC on November 24, 2015)
- Employment Agreement, dated November 16, 2015, between BioTime, Inc. and Russell Skibsted (Filed With SEC on November 16, 2015)
- Stock Purchase Agreements, dated September 14, 2015, between BioTime, Inc. and certain investors (Filed With SEC on November 9, 2015)
- Stock Purchase Agreements between BioTime, Inc. and certain investors (Filed With SEC on November 9, 2015)
- Research & Development Agreement, dated September 29, 2015, between OrthoCyte Corporation and Heraeus Medical GmbH (Portions of this exhibit have been omitted pursuant to a... (Filed With SEC on November 9, 2015)
- License Agreement, dated September 29, 2015, between OrthoCyte Corporation and Heraeus Medical GmbH (Portions of this exhibit have been omitted pursuant to a request for... (Filed With SEC on November 9, 2015)
- Subscription Agreement, dated September 29, 2015, between OncoCyte Corporation and BioTime, Inc (Filed With SEC on November 9, 2015)
- STOCK PURCHASE AGREEMENT (Filed With SEC on October 2, 2015)
- Form of Stock Purchase Agreements (Filed With SEC on September 25, 2015)
- Form of Escrow Agreement (Filed With SEC on September 25, 2015)
- Letter Agreement with Union Underwriting & Finances Ltd (Filed With SEC on September 25, 2015)
- STOCK PURCHASE AGREEMENT (Filed With SEC on September 14, 2015)
- First Amendment to Co-Development and Option Agreement, dated March 7, 2015, between Icahn School of Medicine at Mount Sinai and LifeMap Solutions, Inc. (Portions of this exhibit... (Filed With SEC on May 8, 2015)
- Notice of Grant Award, dated as of October 16, 2014, between the California Institute for Regenerative Medicine and Asterias Biotherapeutics, Inc. (Portions of this exhibit have... (Filed With SEC on March 11, 2015)
- Amendment to Notice of Grant Award, dated as of November 26, 2014, between the California Institute for Regenerative Medicine and Asterias Biotherapeutics, Inc. (Portions of this... (Filed With SEC on March 11, 2015)
- Consulting Agreement, dated December 15, 2014, between BioTime, Inc. and William P. Tew (Filed With SEC on March 11, 2015)
- Employment Agreement, dated December 29, 2014, between BioTime, Inc. Aditya Mohanty (Filed With SEC on March 11, 2015)
- Subscription Agreements between Asterias Biotherapeutics, Inc. and the investors named therein (Filed With SEC on March 11, 2015)
- Underwriting Agreement, dated February 5, 2015, by and between Asterias Biotherapeutics, Inc. and MLV & Co. LLC (Filed With SEC on February 6, 2015)
- Form of Stock Purchase Agreement (Filed With SEC on October 3, 2014)
- Warrant Agreement, dated October 1, 2013, as amended September 19, 2014, between BioTime, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on September 23, 2014)
- Co-Development and Option Agreement, dated May 6, 2014, between LifeMap Solutions, Inc. and the Icahn School of Medicine at Mount Sinai (Portions of this exhibit have been omitted... (Filed With SEC on August 11, 2014)
- Stock Purchase Agreement, dated May 6, 2014, between LifeMap Sciences, Inc. and BioTime, Inc. (Portions of this exhibit have been omitted pursuant to a request for confidential... (Filed With SEC on August 11, 2014)
- Stock Purchase Agreement, dated June 12, 2014, between Pedro Lichtinger and Asterias Biotherapeutics, Inc (Filed With SEC on August 11, 2014)
- Purchase Agreement, dated June 13, 2014, between Broadwood Partners, L.P. and Asterias Biotherapeutics, Inc (Filed With SEC on August 11, 2014)
- Purchase Agreement, dated June 13, 2014, between The George Karfunkel 2007 Grantor Trust #1 and Asterias Biotherapeutics, Inc (Filed With SEC on August 11, 2014)
- Registration Rights Agreement, dated June 16, 2014, between The George Karfunkel 2007 Grantor Trust #1, Broadwood Partners, L.P., and Asterias Biotherapeutics, Inc (Filed With SEC on August 11, 2014)
- Employment Agreement, dated as of June 9, 2014, between Pedro Lichtinger and Asterias Biotherapeutics, Inc (Filed With SEC on August 11, 2014)
- LifeMap Solutions, Inc. 2014 Stock Option Plan (Filed With SEC on August 11, 2014)
- Form of LifeMap Solutions, Inc. Incentive Stock Option Agreement (Filed With SEC on August 11, 2014)
- Form of LifeMap Solutions, Inc. Stock Option Agreement (Filed With SEC on August 11, 2014)
- Amendment No. 1 to Controlled Equity OfferingSM Sales Agreement, dated March 26, 2014, between BioTime, Inc. and Cantor Fitzgerald & Co (Filed With SEC on March 26, 2014)
- Lease, dated December 30, 2013, by and between BMR 6300 Dumbarton Circle, LP, and Asterias Biotherapeutics, Inc (Filed With SEC on March 17, 2014)
- Preferred Stock Purchase Agreement, dated March 4, 2013, between BioTime and certain investors (Filed With SEC on March 17, 2014)
- Option Agreement, dated March 4, 2014, between BioTime and certain investors (Filed With SEC on March 17, 2014)
- _______________ Warrant Agreement Dated as of October 1, 2013 _______________ (Filed With SEC on October 1, 2013)
- Stock and Warrant Purchase Agreement, dated June 3, 2013, between BioTime, Inc. and certain investors (Filed With SEC on August 9, 2013)
- Option Agreement, dated June 3, 2013, between BioTime, Inc. and certain investors (Filed With SEC on August 9, 2013)
- Form of Warrant (Filed With SEC on June 3, 2013)
- Form of Stock and Warrant Purchase Agreement (Filed With SEC on June 3, 2013)
- Client Referral and Solicitation Agreement, dated April 1, 2013, between BioTime, Inc., LifeMap Sciences, Inc. and OBEX Securities, LLC (Filed With SEC on June 3, 2013)
- Engagement Letter, dated May 30, 2013, between BioTime, Inc. and Benjamin & Jerold Brokerage LLC (Filed With SEC on June 3, 2013)
- Engagement Agreement, dated May 30, 2013, between BioTime, Inc. and Scarsdale Equities LLC (Filed With SEC on June 3, 2013)
- Form of Option Agreement (Filed With SEC on June 3, 2013)
- Warrant Agreement between BioTime, Inc. and Romulus Films, Ltd (Filed With SEC on March 18, 2013)
- Amendment to Share Exchange and Contribution Agreement, dated November 30, 2012, by and among LifeMap Sciences, Inc., Alfred D. Kingsley, and Greenway Partners, L.P (Filed With SEC on March 18, 2013)
- Stock and Warrant Purchase Agreement, dated January 4, 2013, between BioTime, Inc. and Romulus Films, Ltd (Filed With SEC on March 18, 2013)
- Stock and Warrant Purchase Agreement, dated January 4, 2013, between BioTime Acquisition Corporation and Romulus Films, Ltd (Filed With SEC on March 18, 2013)
- Business Park Lease, dated January 7, 2013, between David D. Bohannon Organization and BioTime, Inc (Filed With SEC on March 18, 2013)
- Stock Purchase Agreement, dated January 7, 2013, between David D. Bohannon Organization and BioTime, Inc (Filed With SEC on March 18, 2013)
- Amendment of Stock and Warrant Purchase Agreement, dated March 7, 2013, between BioTime, Inc. and Romulus Films, Ltd (Filed With SEC on March 18, 2013)
- Exclusive License Agreement, dated February 15, 2006, between Glycosan BioSystems, Inc. and the University of Utah Research Foundation, as amended (Filed With SEC on November 9, 2012)
- Amendment to Share Exchange and Contribution Agreement, dated September 28, 2012, by and among LifeMap Sciences, Inc., Alfred D. Kingsley, and Greenway Partners, L.P (Filed With SEC on November 9, 2012)
- Share Purchase Agreement, dated November 1, 2012, between Cell Cure Neurosciences, Ltd. and BioTime, Inc (Filed With SEC on November 9, 2012)
- License Option Agreement, dated December 15, 2011 between BioTime, Inc. and USCN Life Sciences, Inc. (Portions of this exhibit have been omitted pursuant to a request for... (Filed With SEC on March 14, 2012)
- LifeMap, Inc. 2011 Stock Option Plan; Form of LifeMap, Inc. Stock Option Agreement (Filed With SEC on March 14, 2012)
- License Agreement between BioTime, Inc. and Cornell University (Portions of this exhibit have been omitted pursuant to a request for confidential treatment) (Filed With SEC on November 8, 2011)
- Employment Agreement, dated October 3, 2011, between BioTime, Inc. and Peter S. Garcia (Filed With SEC on November 8, 2011)
- Employment Agreement, dated June 28, 2011, between BioTime, Inc., OrthoCyte Corporation, and William P. Tew (Filed With SEC on August 9, 2011)
- Warrant Agreement, dated March 21, 2011 (Filed With SEC on May 5, 2011)
- License Agreement, dated February 15, 2006, between the University of Utah and Glycosan BioSystems, Inc., and amendments thereto (Filed With SEC on May 5, 2011)
- LifeMap Sciences, Inc. 2011 Stock Option Plan (Filed With SEC on May 5, 2011)
- Agreement and Plan of Merger, dated February 11, 2010, between Glycosan BioSystems, Inc., OrthoCyte Corporation, and BioTime, Inc (Filed With SEC on March 15, 2011)
- Amended and Restated Shareholders Agreement, dated October 7, 2010, by and among ES Cell International Pte. Ltd, BioTime, Inc., Teva Pharmaceutical Industries, Limited,... (Filed With SEC on March 15, 2011)
- Research and Exclusive License Option Agreement, dated October 7, 2010, between Teva Pharmaceutical Industries, Ltd. and Cell Cure Neurosciences Ltd. (Portions of this exhibit... (Filed With SEC on March 15, 2011)
- Amended and Restated Research and License Agreement, dated October 7, 2010, between Hadasit Medical Research Services and Development Ltd. and Cell Cure Neurosciences Ltd (Filed With SEC on March 15, 2011)
- Additional Research Agreement, dated October 7, 2010, between Hadasit Medical Research Services and Development Ltd. and Cell Cure Neurosciences Ltd (Filed With SEC on March 15, 2011)
- Exclusive License Agreement, dated November 20, 2007, between Cell Targeting, Inc. and Burnham Institute for Medical Research (Filed With SEC on March 15, 2011)
- Stock Purchase Agreement, dated December 29, 2010, between Embryome Sciences, Inc. and Life Extension Foundation (Filed With SEC on March 15, 2011)
- Stock Purchase Agreement, dated December 30, 2010, between Embryome Sciences, Inc. and Geothermal Coring, S.A (Filed With SEC on March 15, 2011)
- Co-Exclusive Supply Agreement, dated December 8, 2010, between BioTime Asia Limited and Shanghai Genext Medical Technology Co. Ltd (Filed With SEC on March 15, 2011)
- OncoCyte Corporation 2010 Stock Option Plan Form of OncoCyte Corporation Stock Option Agreement (Filed With SEC on March 15, 2011)
- OrthoCyte Corporation 2010 Stock Option Plan Form of OrthoCyte Corporation Stock Option Agreement (Filed With SEC on March 15, 2011)
- BioTime Asia, Limited 2010 Stock Option Plan Form of BioTime Asia Limited Stock Option Agreement (Filed With SEC on March 15, 2011)
- ReCyte Therapeutics, Inc. 2010 Stock Option Plan Form of ReCyte Therapeutics, Inc. Stock Option Agreement (Filed With SEC on March 15, 2011)
- Lease, dated October 28, 2010, between SKS Harbor Bay Associates, LLC and BioTime, Inc (Filed With SEC on March 15, 2011)
- Memorandum of Tenancy, Renewal of Tenancy and letters of offer and acceptance of renewal of tenancy between ES Cell International Pte. Ltd. and Jurong Town Corporation (Filed With SEC on March 15, 2011)
- Genome Office Tenancy Renewal, Renewal of Tenancy and letters of offer and acceptance of renewal of tenancy between ES Cell International Pte. Ltd. and Jurong Town Corporation (Filed With SEC on March 15, 2011)
- Sublease Agreement for 20 Biopolis #05-05/06 Centros, Singapore between Bioprocessing Technology Institute, Biomedical Sciences Institutes and ES Cell International Pte Ltd.26 (Filed With SEC on August 16, 2010)
- Memorandum of Tenancy of Biopolis office space, and letters of offer, amendment, and acceptance dated January 2010 between ES Cell International Pte Ltd and JTC Corporation.26 (Filed With SEC on August 16, 2010)
- OrthoCyte Corporation 2010 Stock Option Plan.26 (Filed With SEC on August 16, 2010)
- Warrant Agreement between BioTime, Inc. and Biomedical Sciences Investment Fund Pte Ltd.25 (Filed With SEC on May 5, 2010)
- Employment Agreement, dated August 3, 2009, between BioTime, Inc. and Walter Funk.25 (Filed With SEC on May 5, 2010)
- 2002 Stock Option Plan, as amended (Filed With SEC on November 12, 2009)
- Stock Purchase Agreement between OncoCyte Corporation and George Karfunkel (Filed With SEC on November 12, 2009)
- Registration Rights Agreement between OncoCyte Corporation and George Karfunkel (Filed With SEC on November 12, 2009)
- CO-EXCLUSIVE OEM SUPPLY AGREEMENT (Filed With SEC on August 14, 2009)
- _______________ WarrantAgreement Dated asof May 13, 2009 _______________ (Filed With SEC on May 15, 2009)
- VOIDAFTER 5:00 P.M. NEW YORK TIME, October 31, 2010 (Filed With SEC on May 15, 2009)
- STOCK ANDWARRANT PURCHASE AGREEMENT BIOTIME,INC. 2,200,000Units EachUnit Consisting of One Common Share and OneCommon Share Purchase Warrant Price:$1.8182 per Unit READ THIS... (Filed With SEC on May 15, 2009)
- STOCK ANDWARRANT PURCHASE AGREEMENT BIOTIME,INC. 2,200,000Units EachUnit Consisting of One Common Share and OneCommon Share Purchase Warrant Price:$1.8182 per Unit READ THIS... (Filed With SEC on May 15, 2009)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on May 15, 2009)
- FIFTHAMENDMENT OF REVOLVING LINE OF CREDIT AGREEMENT (Filed With SEC on April 17, 2009)
- AMENDMENT OF REVOLVINGCREDIT NOTE (Filed With SEC on April 17, 2009)
- FIFTH AMENDMENT OF SECURITYAGREEMENT (Filed With SEC on April 17, 2009)
- EXCLUSIVE LICENSEAGREEMENT (Filed With SEC on November 19, 2008)
- EXCLUSIVE SUBLICENSEAGREEMENT (Filed With SEC on November 19, 2008)
- FOURTHAMENDMENT OF REVOLVING LINE OF CREDIT AGREEMENT (Filed With SEC on November 19, 2008)
- FOURTH AMENDMENT OF SECURITYAGREEMENT (Filed With SEC on November 19, 2008)
- LICENSE, PRODUCT PRODUCTION,AND DISTRIBUTION AGREEMENT (Filed With SEC on August 14, 2008)
- EXCLUSIVE LICENSEAGREEMENT (Filed With SEC on August 14, 2008)
- Third Amended and Restated Revolving Line of Credit Agreement, dated March 31, 2008 (Filed With SEC on April 4, 2008)
- Third Amended and Restated Security Agreement, dated March 31, 2008 (Filed With SEC on April 4, 2008)
- Second Amended and Restated Revolving Line of Credit Agreement, dated February 15, 2008 (Filed With SEC on March 10, 2008)
- Form of Amended and Restated Revolving Credit Note (Filed With SEC on March 10, 2008)
- Second Amended and Restated Security Agreement, dated February 15, 2008 (Filed With SEC on March 10, 2008)
- Commercial License and Option Agreement between BioTime and Wisconsin Alumni Research Foundation (Filed With SEC on January 9, 2008)
- FIRST AMENDED AND RESTATED REVOLVING LINE OF CREDIT AGREEMENT by and among BIOTIME, INC. as Borrower and ALFRED D. KINGSLEY, GEORGE KARFUNKEL, RICHARD LOWISH, and BROADWOOD... (Filed With SEC on October 19, 2007)
- AMENDED AND RESTATED REVOLVING CREDIT NOTE (Filed With SEC on October 19, 2007)
- REVOLVING CREDIT NOTE (Filed With SEC on October 19, 2007)
- FIRST AMENDED AND RESTATED SECURITY AGREEMENT (Filed With SEC on October 19, 2007)
- REVOLVING LINE OF CREDIT AGREEMENT (Filed With SEC on April 17, 2006)
- SECURITY AGREEMENT (Filed With SEC on April 17, 2006)
- REVOLVING CREDIT NOTE $166,666.67 April 12, 2006 (Filed With SEC on April 17, 2006)
- ADDENDUM No. 5 TO LEASE (Filed With SEC on March 29, 2004)
- CURRENT ASSETS (Filed With SEC on August 14, 2002)